Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up - Wikidata - wikimedia - TriplyDB

Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up

Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up

http://www.wikidata.org/entity/Q34271299

about

Interventions to improve antibiotic prescribing practices for hospital inpatients.Procalcitonin-guided diagnosis and antibiotic stewardship revisited.Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation.Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review.Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.

P2860

Q34550823-68BAEA3F-700F-42C2-9246-D794415958F0 Q36257991-0C571B9A-32F8-40D8-B6DD-FF8DA554FF85 Q40809434-271C3815-A6D1-441F-A04A-05E6AA73147D Q41917921-5BBD3312-55D1-4640-8DD0-24828707A5CF Q53281681-9AF4EE4B-9FA0-4BCD-848C-84E5FE3649EA Q55022514-D0C7817C-BE3A-46F3-824E-630B9C4584F6

P2860

Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up

http://www.wikidata.org/entity/Q34271299

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Procalcitonin guidance for red ...... study with 12-month follow-up

@ast

Procalcitonin guidance for red ...... study with 12-month follow-up

@en

Procalcitonin guidance for red ...... study with 12-month follow-up

@nl

type

label

Procalcitonin guidance for red ...... study with 12-month follow-up

@ast

Procalcitonin guidance for red ...... study with 12-month follow-up

@en

Procalcitonin guidance for red ...... study with 12-month follow-up

@nl

prefLabel

Procalcitonin guidance for red ...... study with 12-month follow-up

@ast

Procalcitonin guidance for red ...... study with 12-month follow-up

@en

Procalcitonin guidance for red ...... study with 12-month follow-up

@nl

P1433

Q34271299-AC2E163E-A807-4EFD-B251-62CBF5B188F6

P1476

Q34271299-CC3C4EC3-E0E7-47D6-B86C-EB2BAC8B3BF9

P2093

Q34271299-2D121C7C-2FAB-47CE-975D-B22DB124E8E5

Q34271299-579DDE9E-719B-4C1D-A054-1AEFEFE843B4

Q34271299-84193135-2C37-4FD6-AE3E-6BB663D7D718

Q34271299-B850B429-A7D9-41E0-956F-C17237B138AF

Q34271299-BBF643DD-AD40-4318-9478-346E4913A494

Q34271299-C1384D19-597E-4885-A39F-92DDEEB5AB2D

Q34271299-EB8B75DF-B63D-4DB9-8FED-431621E56510

P2860

Q34271299-013613DC-759F-4561-89F8-440844E609B7

Q34271299-0FC1B045-7641-4DAE-8E3A-D1544C3CBE45

Q34271299-1B76B036-6341-4A5A-B0A1-E182E980E083

Q34271299-1D08DBF2-98CA-47D2-9EAB-E7302DFF838A

Q34271299-1F9C2BEC-5094-459D-A7AC-9234DE5FAA67

Q34271299-20118D67-80EA-4120-8C4E-8C23B034F01D

Q34271299-236D5800-10E6-4879-BEDE-B67ECFBFE507

Q34271299-358DFD6F-5FDD-4A4B-B5D1-CF4184CB8D87

Q34271299-3EFCC9F3-085D-48C4-BC1E-02BFF0973DA2

Q34271299-43705A38-449E-4917-9478-B2688FB927CC

P2888

Q34271299-A747FFA9-47F2-4E3E-8F22-70B7FCE47F77

P304

Q34271299-D27023C2-5F01-451C-9F30-A711FB3FE75D

P31

Q34271299-661E60EC-554D-482F-9018-CEA762BAA1DF

P356

Q34271299-B782B5E2-DBD4-4B82-8A85-5377DF591A39

P433

Q34271299-8ADD83F2-6FE3-495F-BF1E-B2F666C4842D

P478

Q34271299-0D87F159-F60C-426A-9203-981F6FE8B2AB

P50

Q34271299-1BB0B5E1-819F-4913-90CE-06BD3CC4FBBB

P577

Q34271299-89E333C2-0323-4E45-AB3F-8D958CB3038B

P5875

Q34271299-84EA137D-FDEF-40B1-BDB2-167FD851A251

P6179

Q34271299-C6F8B3F9-AC63-4FA6-BEB8-97EB89BA234C

P698

Q34271299-7144D922-7A34-42B2-A32C-54A2C7ACAFF9

P921

Q34271299-3FE10AFB-1CBF-4778-A71E-FEBE3F70CEE4

Q34271299-79492895-5C40-4138-B746-C67A77DF4508

P932

Q34271299-6F4A15E0-5E72-469E-8DAF-EE67089858C1

P356

S13054-014-0471-7

P1433

P1476

Procalcitonin guidance for red ...... study with 12-month follow-up

@en

P2093

Gang Lu

http://www.w3.org/2001/XMLSchema#string

Gao-Zhong Huang

http://www.w3.org/2001/XMLSchema#string

Jian-Guo Tang

http://www.w3.org/2001/XMLSchema#string

Li-Juan Li

http://www.w3.org/2001/XMLSchema#string

Xue-Min Zhang

http://www.w3.org/2001/XMLSchema#string

Yi-Cui Zhang

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

The global burden of asthma: executive summary of the GINA Dissemination Committee report

Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.

Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

P2888

s13054-014-0471-7

P304

471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13054-014-0471-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265392509

http://www.w3.org/2001/XMLSchema#string

P6179

1019214294

http://www.w3.org/2001/XMLSchema#string

P698

25189222

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

4180966

http://www.w3.org/2001/XMLSchema#string